Business Context and Reporting Period
This Form 8-K is a current report filed by Health In Tech, Inc. (Nasdaq: HIT) on April 27, 2026. The filing addresses a change in executive leadership and the subsequent engagement of the departing officer as a consultant.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and contractual arrangements rather than financial performance.
Material Changes
- Executive Departure: Dustin Plantholt departed his role as Chief AI & Marketing Officer effective April 30, 2026. The departure is described as part of a business transition with no disagreement regarding operations or policies.
- New Consulting Arrangement: HITChain Inc., a subsidiary, entered into an independent contractor agreement with Plantholt Advisory Group LLC, effective May 1, 2026.
- Compensation Structure: The agreement includes monthly compensation for services and a grant of 500,000 restricted shares of HITChain common stock.
- Vesting Terms: The restricted stock award vests in equal monthly installments over 12 months, contingent on continued service.
- Termination Clause: The consulting agreement may be terminated by either party with 10 days' prior written notice.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or specific risk factors beyond the standard disclosure that the summary of the consulting agreement is qualified by reference to the full text filed as Exhibit 10.1.
Investor Verification Checklist
- Verify the specific monthly compensation amount in the full Consulting Agreement (Exhibit 10.1), as the filing only states compensation is provided without specifying the figure.
- Confirm the current valuation and trading status of HITChain Inc. common stock to assess the value of the 500,000 restricted shares granted.
- Review the specific deliverables and scope of services outlined in the Consulting Agreement to understand the ongoing role of the former officer.
- Monitor future filings for any changes in the vesting schedule or early termination of the consulting arrangement.